NO20002828D0 - Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav - Google Patents
Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling deravInfo
- Publication number
- NO20002828D0 NO20002828D0 NO20002828A NO20002828A NO20002828D0 NO 20002828 D0 NO20002828 D0 NO 20002828D0 NO 20002828 A NO20002828 A NO 20002828A NO 20002828 A NO20002828 A NO 20002828A NO 20002828 D0 NO20002828 D0 NO 20002828D0
- Authority
- NO
- Norway
- Prior art keywords
- serogroup
- preparation
- vaccine against
- against neisseria
- proteinaceous vaccine
- Prior art date
Links
- 241000588653 Neisseria Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20002828A NO20002828D0 (no) | 2000-06-02 | 2000-06-02 | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
US10/296,212 US20040131642A1 (en) | 2000-06-02 | 2001-06-05 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
APAP/P/2002/002681A AP1690A (en) | 2000-06-02 | 2001-06-05 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup A and process for the production thereof. |
AU2001264427A AU2001264427A1 (en) | 2000-06-02 | 2001-06-05 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
OA1200200362A OA12278A (en) | 2000-06-02 | 2001-06-05 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup A and process for the production thereof. |
AT01938851T ATE345143T1 (de) | 2000-06-02 | 2001-06-05 | Impfstoff umfassend aussenmembranvesikel gegen krankheiten verursacht durch i neisseria meningitidis/i serogruppe a und verfahren zur herstellung desselben |
EP01938851A EP1286696B1 (en) | 2000-06-02 | 2001-06-05 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
PCT/NO2001/000232 WO2001091788A1 (en) | 2000-06-02 | 2001-06-05 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
DE60124538T DE60124538D1 (de) | 2000-06-02 | 2001-06-05 | Impfstoff umfassend aussenmembranvesikel gegen krankheiten verursacht durch i neisseria meningitidis/i serogruppe a und verfahren zur herstellung desselben |
CA002410652A CA2410652A1 (en) | 2000-06-02 | 2001-06-05 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20002828A NO20002828D0 (no) | 2000-06-02 | 2000-06-02 | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20002828D0 true NO20002828D0 (no) | 2000-06-02 |
Family
ID=19911219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20002828A NO20002828D0 (no) | 2000-06-02 | 2000-06-02 | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040131642A1 (no) |
EP (1) | EP1286696B1 (no) |
AP (1) | AP1690A (no) |
AT (1) | ATE345143T1 (no) |
AU (1) | AU2001264427A1 (no) |
CA (1) | CA2410652A1 (no) |
DE (1) | DE60124538D1 (no) |
NO (1) | NO20002828D0 (no) |
OA (1) | OA12278A (no) |
WO (1) | WO2001091788A1 (no) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100338218C (zh) | 1999-05-19 | 2007-09-19 | 启龙股份公司 | 组合式奈瑟球菌组合物 |
GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
WO2002009643A2 (en) | 2000-07-27 | 2002-02-07 | Children's Hospital & Research Center At Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
GB0130123D0 (en) | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
EP1562982B1 (en) | 2002-11-15 | 2010-05-05 | Novartis Vaccines and Diagnostics S.r.l. | Unexpected surface proteins in neisseria meningitidis |
CU23313A1 (es) * | 2002-11-27 | 2008-09-25 | Inst Finlay Ct De Investigacia | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
WO2004054611A1 (en) * | 2002-12-16 | 2004-07-01 | Nasjonalt Folkehelseinstitutt | Meningococcal vaccine based on outer membrane proteins porb2 and pora |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
CU23377A1 (es) * | 2003-11-04 | 2009-05-28 | Ct De Ingenieria Genetica Y Biotecnologia | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes |
GB0416120D0 (en) | 2004-07-19 | 2004-08-18 | Health Prot Agency | Stable compositions containing OMV's |
GB0419627D0 (en) | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
ATE496987T1 (de) | 2006-05-22 | 2011-02-15 | Biovest Int Inc | Ausserkapilläres fluidzirkulationssystem und - verfahren |
EP2200642B1 (en) | 2007-10-19 | 2012-04-18 | Novartis AG | Meningococcal vaccine formulations |
US9579372B2 (en) | 2008-02-21 | 2017-02-28 | Glaxosmithkline Biologicals Sa | Meningococcal fHBP polypeptides |
PL2268618T3 (pl) | 2008-03-03 | 2015-11-30 | Novartis Ag | Związki i kompozycje jako modulatory aktywności receptorów TLR |
RU2477145C2 (ru) * | 2008-05-30 | 2013-03-10 | ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ | Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения |
GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
MX2011006648A (es) | 2008-12-17 | 2011-10-14 | Novartis Ag | Vacunas meningococales que incluyen receptor de hemoglobina. |
US9517263B2 (en) | 2009-06-10 | 2016-12-13 | Glaxosmithkline Biologicals Sa | Benzonaphthyridine-containing vaccines |
US20110076300A1 (en) | 2009-08-27 | 2011-03-31 | Mariagrazia Pizza | Hybrid Polypeptides Including Meningococcal fHBP Sequences |
WO2011024071A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
SG178954A1 (en) | 2009-09-02 | 2012-04-27 | Novartis Ag | Immunogenic compositions including tlr activity modulators |
TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為tlr活性調節劑之化合物及組合物 |
GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
EP2483390A2 (en) | 2009-09-30 | 2012-08-08 | Novartis AG | Expression of meningococcal fhbp polypeptides |
CA2779816A1 (en) | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
SG181712A1 (en) | 2009-12-15 | 2012-07-30 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
US20130071422A1 (en) | 2010-03-18 | 2013-03-21 | Michele Pallaoro | Adjuvanted vaccines for serogroup b meningococcus |
KR101853513B1 (ko) | 2010-03-23 | 2018-04-30 | 노파르티스 아게 | 감염, 염증, 호흡기 질환 등의 치료를 위해 사용되는 tlr2 효능제로서의 화합물 (시스테인 기재 리포펩티드) 및 조성물 |
EP2613805B1 (en) | 2010-09-10 | 2019-10-23 | GlaxoSmithKline Biologicals SA | Meningococcus overexpressing nada and/or nhba and outer membrane vesicles derived therefrom |
EP2707009A1 (en) | 2011-05-12 | 2014-03-19 | Novartis AG | Antipyretics to enhance tolerability of vesicle-based vaccines |
WO2012171030A2 (en) | 2011-06-10 | 2012-12-13 | Biovest International, Inc. | Method and apparatus for antibody production and purification |
BR112014019166A2 (pt) | 2012-02-02 | 2017-07-04 | Novartis Ag | promotores para expressão aumentada de proteína em meningococos |
WO2013132040A2 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | In vitro potency assay for protein-based meningococcal vaccines |
EP2861247B1 (en) | 2012-06-14 | 2020-12-09 | GlaxoSmithKline Biologicals SA | Vaccines for serogroup x meningococcus |
WO2014036187A1 (en) | 2012-08-28 | 2014-03-06 | Biovest International, Inc. | Biomanufacturing suite and methods for large-scale production of cells, viruses, and biomolecules |
RU2015106930A (ru) | 2012-09-06 | 2016-10-20 | Новартис Аг | Комбинированные вакцины с менингококком серогруппы в и к/д/с |
EP4056198A3 (en) | 2012-09-18 | 2022-12-07 | GlaxoSmithKline Biologicals SA | Outer membrane vesicles |
US20160120818A1 (en) | 2013-02-07 | 2016-05-05 | Glaxosmithline Biological Sa | Pharmaceutical compositions comprising vesicles |
WO2015128480A1 (en) | 2014-02-28 | 2015-09-03 | Novartis Ag | Modified meningococcal fhbp polypeptides |
EP3838918B1 (en) | 2015-05-18 | 2022-08-31 | BiOMVis Srl | Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof |
US20190282684A1 (en) | 2016-09-02 | 2019-09-19 | Glaxosmithkline Biologicals, S.A. | Vaccines for neisseria gonorrhoeae |
EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
MX2021005303A (es) | 2018-11-06 | 2021-07-07 | Glaxosmithkline Biologicals Sa | Composiciones inmunogenicas. |
CN112410239B (zh) * | 2019-08-22 | 2023-03-24 | 四川大学 | 细菌膜囊泡及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE198834T1 (de) * | 1991-03-12 | 2001-02-15 | Us Health | Konjugate bestehend aus polysaccharid und protein |
US5324442A (en) * | 1992-06-16 | 1994-06-28 | Kansas State University Research Foundation | Fermentation process for the production of calcium magnesium road deicer |
GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
DK1047784T4 (en) * | 1998-01-14 | 2015-06-15 | Novartis Vaccines & Diagnostic | NEISSERA meningitidis ANTIGENS |
GB9820003D0 (en) * | 1998-09-14 | 1998-11-04 | Smithkline Beecham Biolog | Novel compounds |
WO2000042193A1 (en) * | 1999-01-15 | 2000-07-20 | Smithkline Beecham Biologicals S.A. | Neisseria meningitidis antigen |
DE60031244T2 (de) * | 1999-02-22 | 2007-05-24 | Ncsrt, Inc. | Reinigung von biologischen substanzen |
GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
WO2002009643A2 (en) * | 2000-07-27 | 2002-02-07 | Children's Hospital & Research Center At Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
GB0103170D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
GB0024200D0 (en) * | 2000-10-03 | 2000-11-15 | Smithkline Beecham Sa | Component vaccine |
-
2000
- 2000-06-02 NO NO20002828A patent/NO20002828D0/no unknown
-
2001
- 2001-06-05 OA OA1200200362A patent/OA12278A/en unknown
- 2001-06-05 AU AU2001264427A patent/AU2001264427A1/en not_active Abandoned
- 2001-06-05 AP APAP/P/2002/002681A patent/AP1690A/en active
- 2001-06-05 AT AT01938851T patent/ATE345143T1/de not_active IP Right Cessation
- 2001-06-05 DE DE60124538T patent/DE60124538D1/de not_active Expired - Lifetime
- 2001-06-05 WO PCT/NO2001/000232 patent/WO2001091788A1/en active IP Right Grant
- 2001-06-05 CA CA002410652A patent/CA2410652A1/en not_active Abandoned
- 2001-06-05 EP EP01938851A patent/EP1286696B1/en not_active Revoked
- 2001-06-05 US US10/296,212 patent/US20040131642A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2001264427A1 (en) | 2001-12-11 |
EP1286696A1 (en) | 2003-03-05 |
AP2002002681A0 (en) | 2002-12-31 |
EP1286696B1 (en) | 2006-11-15 |
US20040131642A1 (en) | 2004-07-08 |
CA2410652A1 (en) | 2001-12-06 |
ATE345143T1 (de) | 2006-12-15 |
WO2001091788A1 (en) | 2001-12-06 |
OA12278A (en) | 2006-05-11 |
AP1690A (en) | 2006-12-11 |
DE60124538D1 (de) | 2006-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20002828D0 (no) | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav | |
FR22C1001I1 (fr) | Vaccin conjugué de protéine et de polysaccharide pour méningococcie polyvalente | |
IL205958A0 (en) | Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein | |
DK1228217T3 (da) | Konserverede neisseria-antigener | |
CY2009014I2 (el) | Εμβολιο εναντι αντιγονων απο βακτηριδια | |
CY2006004I2 (el) | Μεθοδος διαχωρισμου παραλλαγων ροταϊου και ζωντανο εξασθενημενο εμβολιο ροταϊου | |
NO20031483L (no) | Vaksine | |
DE60142978D1 (de) | Chirurgisches zugangsgerät und -verfahren | |
FI20001997A (fi) | Poikkeamien havaintimekanismi ja menetelmä sen opettamiseksi | |
NO20031274D0 (no) | Anvendelse av immidazokinolinaminer som adjuvanser i DNA- vaksinasjon | |
NO20024172D0 (no) | Vaksine | |
DE60118440D1 (de) | Start- und antriebsstrangstossschutz-steuerverfahren und -system | |
AU2001261144A1 (en) | Ultrasonic dosage device and method | |
NO20004907D0 (no) | Vandig emulsjon og fremstilling derav | |
DK1281616T3 (da) | Væskepåfyldningsmetode | |
DE60144460D1 (de) | Akustische Oberflächenwellenanordnung und Verfahren zu ihrer Herstellung | |
NO20034413D0 (no) | Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst | |
FI20002329A0 (fi) | Pakettikytkennäinen äänitysmenetelmä ja laite | |
DE60110736D1 (de) | Fotobearbeitungsverfahren und -gerät | |
AU2001269640A1 (en) | Vaccine against the influenza virus and method for producing said virus vaccine | |
AU6964001A (en) | Vaccine against the influenza virus and method for producing said virus vaccine | |
FI20030901A (fi) | Vakiovoimamenetelmä ja -laite | |
AU2001292398A1 (en) | Device and method of catechetic study utilizing barcodes | |
IT1319223B1 (it) | Metodo e prodotto per la preparazione di un intonaco decorativo eprocedimento per la sua applicazione. | |
FR2811754B1 (fr) | Vibrometre universel |